In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020

Yuag Meng Liu; Wen Chien Ko; Mao Wang Ho; Yu Lin Lee; Po Ren Hsueh

doi:10.1016/j.jinf.2022.10.038

In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020

Yuag Meng Liu, Wen Chien Ko, Mao Wang Ho, Yu Lin Lee, Po Ren Hsueh

內科學科

研究成果: Letter › 同行評審

4 引文斯高帕斯（Scopus）

原文	English
頁（從 - 到）	66-117
頁數	52
期刊	Journal of Infection
卷	86
發行號	1
DOIs	https://doi.org/10.1016/j.jinf.2022.10.038
出版狀態	Published - 2023 1月

All Science Journal Classification (ASJC) codes

微生物學（醫學）
傳染性疾病

存取文件

10.1016/j.jinf.2022.10.038

其它文件與鏈接

引用此

@article{80725064e1cb4f54b6fbaec763cde3d0,

title = "In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020",

author = "Liu, {Yuag Meng} and Ko, {Wen Chien} and Ho, {Mao Wang} and Lee, {Yu Lin} and Hsueh, {Po Ren}",

note = "Funding Information: Investigators associated with the SMART Taiwan Group in 2020: Po-Ren Hsueh (China Medical University Hospital, Taichung, Taiwan), Wen-Chien Ko (National Cheng Kung University Hospital, Tainan, Taiwan), Po-Liang Lu (Kaohsiung Medical University Hospital, Kaohsiung, Taiwan), Chun-Eng Liu (Changhua Christian Hospital, Changhua, Taiwan), Hung-Jen Tang (Chi-Mei Medical Centre, Tainan, Taiwan), Fu-Der Wang (Taipei Veterans General Hospital, Taipei, Taiwan), Yao-Shen Chen (Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan), Shih-Ming Tsao (Chung Shan Medical University Hospital, Taichung, Taiwan), and Mao-Wang Ho (China Medical University Hospital, Taichung, Taiwan). Funding Information: This study was supported by Merck & Co., Inc. (Rahway, NJ, USA) ",

year = "2023",

month = jan,

doi = "10.1016/j.jinf.2022.10.038",

language = "English",

volume = "86",

pages = "66--117",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan

T2 - Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020

AU - Liu, Yuag Meng

AU - Ko, Wen Chien

AU - Ho, Mao Wang

AU - Lee, Yu Lin

AU - Hsueh, Po Ren

N1 - Funding Information: Investigators associated with the SMART Taiwan Group in 2020: Po-Ren Hsueh (China Medical University Hospital, Taichung, Taiwan), Wen-Chien Ko (National Cheng Kung University Hospital, Tainan, Taiwan), Po-Liang Lu (Kaohsiung Medical University Hospital, Kaohsiung, Taiwan), Chun-Eng Liu (Changhua Christian Hospital, Changhua, Taiwan), Hung-Jen Tang (Chi-Mei Medical Centre, Tainan, Taiwan), Fu-Der Wang (Taipei Veterans General Hospital, Taipei, Taiwan), Yao-Shen Chen (Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan), Shih-Ming Tsao (Chung Shan Medical University Hospital, Taichung, Taiwan), and Mao-Wang Ho (China Medical University Hospital, Taichung, Taiwan). Funding Information: This study was supported by Merck & Co., Inc. (Rahway, NJ, USA)

PY - 2023/1

Y1 - 2023/1

UR - http://www.scopus.com/inward/record.url?scp=85144637377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144637377&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2022.10.038

DO - 10.1016/j.jinf.2022.10.038

M3 - Letter

C2 - 36336172

AN - SCOPUS:85144637377

SN - 0163-4453

VL - 86

SP - 66

EP - 117

JO - Journal of Infection

JF - Journal of Infection

IS - 1

ER -